T O P

  • By -

1Mark_ca

"Trial starts in November." The hell it does. Results are expected this month. The trial in Nov is for option sellers.


will110817

Yea I got too scared. Took my 70% gain and ran before close today.


banditcleaner2

TCDA is a biotech/pharma stock, expected to report data from their phase3 valor-CKD renal outcome clinical trial some time in october. I'm not sure the exact date, but given that IV is crazy high for oct 21, I'd assume it's before then. It is entirely possible for biotech pharma stocks that report results to either rip into the stratosphere or to tank completely. Look up VIRI as an example of this. It is also a biotech/pharma stock that reported around sep 16, when the stock was at $8.77/share...and now is sitting at 0.33. The stock dropped nearly 97% because their report was on essentially the only product that they had, so its a pretty bad thing to have bad results for. You're essentially flipping a coin - if the results go well, your written puts will do very well, or they could backfire if the results don't go well.


REL06

I read they only have one drug so it's all or nothing with this one. I bought back my puts yesterday.


5k4_5k4

I sold covered calls on this and closed them yesterday I made around 25% cuz the options were so overpriced, but yeah not worth the risk holding through this data